AMICUS THERAPEUTICS, INC. — Director's Dealing 2014

Nov 25, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2014-11-25

Reporting Person: Castelli Jeff (VP, Program Management)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-25	Common stock	P	8103	$8.00	Acquired	58103	Direct
2014-11-25	Common stock	S	8103	$8.00	Disposed	50000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-25	Stock Options (right to buy)	$3.53	M	8103	Disposed	2023-01-28	Common Stock (8103)	Direct

Footnotes

F1: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2014.